J. Tegeler

1.5k total citations
41 papers, 929 citations indexed

About

J. Tegeler is a scholar working on Psychiatry and Mental health, Clinical Psychology and Pharmacology. According to data from OpenAlex, J. Tegeler has authored 41 papers receiving a total of 929 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Psychiatry and Mental health, 10 papers in Clinical Psychology and 7 papers in Pharmacology. Recurrent topics in J. Tegeler's work include Schizophrenia research and treatment (21 papers), Bipolar Disorder and Treatment (10 papers) and Electroconvulsive Therapy Studies (8 papers). J. Tegeler is often cited by papers focused on Schizophrenia research and treatment (21 papers), Bipolar Disorder and Treatment (10 papers) and Electroconvulsive Therapy Studies (8 papers). J. Tegeler collaborates with scholars based in Germany, Switzerland and United States. J. Tegeler's co-authors include Michael Linden, F. Müller‐Spahn, Péter Müller, Wolfgang Gäebel, Wolfgang Köpcke, A. Pietzcker, Michael Osterheider, Heinrich Sauer, W. Greil and Tilman Wetterling and has published in prestigious journals such as The British Journal of Psychiatry, Journal of Affective Disorders and Schizophrenia Bulletin.

In The Last Decade

J. Tegeler

40 papers receiving 868 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Tegeler Germany 15 817 289 217 126 92 41 929
David A. Curson United Kingdom 15 678 0.8× 238 0.8× 238 1.1× 111 0.9× 68 0.7× 21 804
S. Brook South Africa 17 1.2k 1.5× 422 1.5× 74 0.3× 151 1.2× 190 2.1× 38 1.4k
Teresa Díez Spain 12 806 1.0× 324 1.1× 126 0.6× 104 0.8× 36 0.4× 30 1.1k
Eugene M. Caffey United States 13 486 0.6× 199 0.7× 91 0.4× 89 0.7× 62 0.7× 24 643
Hany G El-Sayeh United Kingdom 11 695 0.9× 221 0.8× 183 0.8× 134 1.1× 64 0.7× 22 931
Jordan Bertsch Spain 14 552 0.7× 278 1.0× 81 0.4× 84 0.7× 27 0.3× 24 763
Karen C. Tugrul United States 9 634 0.8× 216 0.7× 27 0.1× 57 0.5× 129 1.4× 12 753
Amelia Nasrallah United States 16 494 0.6× 165 0.6× 44 0.2× 194 1.5× 26 0.3× 22 656
Carrie L. Ernst United States 16 489 0.6× 324 1.1× 36 0.2× 68 0.5× 86 0.9× 29 862
Nael Kilzieh United States 10 414 0.5× 168 0.6× 54 0.2× 87 0.7× 29 0.3× 16 561

Countries citing papers authored by J. Tegeler

Since Specialization
Citations

This map shows the geographic impact of J. Tegeler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Tegeler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Tegeler more than expected).

Fields of papers citing papers by J. Tegeler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Tegeler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Tegeler. The network helps show where J. Tegeler may publish in the future.

Co-authorship network of co-authors of J. Tegeler

This figure shows the co-authorship network connecting the top 25 collaborators of J. Tegeler. A scholar is included among the top collaborators of J. Tegeler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Tegeler. J. Tegeler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Busch, H, et al.. (2015). Particular Aspects of the Interrater Reliability of the AMDP Psychopathology Scale. PubMed. 20. 125–142. 2 indexed citations
2.
Godemann, F., Michael Linden, Wolfgang Gäebel, et al.. (2003). Is interval medication a successful treatment regimen for schizophrenic patients with critical attitudes towards treatment?⋆. European Psychiatry. 18(2). 82–84. 8 indexed citations
3.
Gäebel, Wolfgang, M Jänner, Nicole Frommann, et al.. (2002). First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies. Schizophrenia Research. 53(1-2). 145–159. 86 indexed citations
4.
Linden, Michael, F. Godemann, Wolfgang Gäebel, et al.. (2001). A Prospective Study of Factors Influencing Adherence to a Continuous Neuroleptic Treatment Program in Schizophrenia Patients During 2 Years. Schizophrenia Bulletin. 27(4). 585–596. 50 indexed citations
5.
Gäebel, Wolfgang, M Jänner, Nicole Frommann, et al.. (2000). Prodromal States in Schizophrenia. Comprehensive Psychiatry. 41(2). 76–85. 18 indexed citations
6.
Finkbeiner, Thomas, et al.. (1998). Positiv-und Negativsymptomatik bei chronisch schizophrenen Patienten unter Erhaltungstherapie mit Flupentixol-Decanoat im 12-Monats-Verlauf. Fortschritte der Neurologie · Psychiatrie. 66(10). 442–449. 7 indexed citations
7.
Greil, W., Wolfgang Ludwig‐Mayerhofer, N. Erazo, et al.. (1997). Lithium vs carbamazepine in the maintenance treatment of schizoaffective disorder: a randomised study. European Archives of Psychiatry and Clinical Neuroscience. 247(1). 42–50. 53 indexed citations
8.
Greil, W., Wolfgang Ludwig‐Mayerhofer, N. Erazo, et al.. (1996). Comparative efficacy of lithium and amitriptyline in the maintenance treatment of recurrent unipolar depression: a randomised study. Journal of Affective Disorders. 40(3). 179–190. 29 indexed citations
9.
Greil, W., Wolfgang Ludwig‐Mayerhofer, Adelheid Czernik, et al.. (1993). The recruitment process for a multicenter study on the long-term prophylactic treatment of affective disorders. Journal of Affective Disorders. 28(4). 257–265. 25 indexed citations
10.
Bandelow, Borwin, Péter Müller, Ulrich Frick, et al.. (1992). Depressive syndromes in schizophrenic patients under neuroleptic therapy. European Archives of Psychiatry and Clinical Neuroscience. 241(5). 291–295. 20 indexed citations
11.
Müller, Péter, Borwin Bandelow, Wolfgang Gäebel, et al.. (1992). Intermittent Medication, Coping and Psychotherapy Interactions in Relapse Prevention and Course Modification. The British Journal of Psychiatry. 161(S18). 140–144. 4 indexed citations
12.
Bandelow, Borwin, Péter Müller, Wolfgang Gäebel, et al.. (1990). Depressive syndromes in schizophrenic patients after discharge from hospital. European Archives of Psychiatry and Clinical Neuroscience. 240(2). 113–120. 19 indexed citations
13.
Tegeler, J., et al.. (1990). Safety of Long-Term Neuroleptanxiolysis with Fluspirilene 1.5 mg per Week. Pharmacopsychiatry. 23(6). 259–264. 4 indexed citations
14.
Tegeler, J., et al.. (1990). Double-blind Study of the Therapeutic Efficacy and Tolerability of Amitriptylinoxide in Comparison with Amitriptyline. Pharmacopsychiatry. 23(1). 45–49. 6 indexed citations
15.
16.
Tegeler, J., et al.. (1988). Cognitive Functions in Schizophrenic Patients with Tardive Dyskinesia. Pharmacopsychiatry. 21(6). 308–309. 2 indexed citations
17.
Wöller, Wolfgang, et al.. (1984). [Lithium in the treatment of periodically occurring catatonic arousal states in schizophrenic patients].. PubMed. 55(7). 382–4. 1 indexed citations
18.
Lehmann, E., et al.. (1984). Comparison of the Antidepressant Action of Tryptophan, Tryptophan/5-Hydroxytryptophan Combination and Nomifensine. Neuropsychobiology. 11(2). 111–115. 12 indexed citations
19.
Busch, H, et al.. (1980). Reliability of the AMDP‐System A PRELIMINARY REPORT ON A MULTICENTRE EXERCISE ON THE RELIABILITY OF PSYCHOPATHOLOGICAL ASSESSMENT. Acta Psychiatrica Scandinavica. 62(4). 382–391. 22 indexed citations
20.
Lehmann, E., et al.. (1980). Wirkungsdifferenzen bei Hoch- und Standarddosierung von Fluphenazin-Decanoat in Abhängigkeit von Patienten- Merkmalen. Pharmacopsychiatry. 13(3). 117–129. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David A. Curson Breakdown of academic impact, for papers by S. Brook Breakdown of academic impact, for papers by Teresa Díez Breakdown of academic impact, for papers by Eugene M. Caffey Breakdown of academic impact, for papers by Hany G El-Sayeh Breakdown of academic impact, for papers by Jordan Bertsch Breakdown of academic impact, for papers by Karen C. Tugrul Breakdown of academic impact, for papers by Amelia Nasrallah Breakdown of academic impact, for papers by Carrie L. Ernst Breakdown of academic impact, for papers by Nael Kilzieh
Rankless by CCL
2026